BeiGene, Ltd.
ONC
$221.88
$1.930.88%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 48.64% | 84.84% | 41.17% | 56.09% | 67.85% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 48.64% | 84.84% | 41.17% | 56.09% | 67.85% |
| Cost of Revenue | 32.07% | 54.59% | 106.01% | 43.90% | 52.75% |
| Gross Profit | 51.95% | 91.21% | 32.78% | 58.44% | 71.23% |
| SG&A Expenses | 7.45% | 31.39% | 34.08% | 12.33% | 30.12% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -105.26% | 105.48% | -- | -- |
| Total Operating Expenses | 9.20% | 23.34% | 38.88% | 13.39% | 23.68% |
| Operating Income | 104.25% | 80.34% | -24.37% | 66.38% | 29.60% |
| Income Before Tax | 108.59% | 79.52% | -162.46% | 71.18% | 27.75% |
| Income Tax Expenses | 154.14% | 417.66% | 8.87% | 5.93% | -32.79% |
| Earnings from Continuing Operations | 100.51% | 58.27% | -175.63% | 68.41% | 27.92% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 100.51% | 58.27% | -175.63% | 68.41% | 27.92% |
| EBIT | 104.25% | 80.34% | -24.37% | 66.38% | 29.60% |
| EBITDA | 118.01% | 90.73% | -26.98% | 71.94% | 32.61% |
| EPS Basic | 100.49% | 59.13% | -175.81% | 68.43% | 27.99% |
| Normalized Basic EPS | 109.28% | 90.82% | -157.98% | 71.40% | 28.48% |
| EPS Diluted | 100.46% | 59.13% | -175.81% | 68.43% | 26.16% |
| Normalized Diluted EPS | 108.93% | 90.82% | -157.98% | 71.40% | 28.48% |
| Average Basic Shares Outstanding | 2.55% | 2.10% | -0.23% | 0.06% | 0.10% |
| Average Diluted Shares Outstanding | 6.62% | 2.10% | -0.23% | 0.06% | 0.10% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -2.23% | -- | -- |